Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase

Recruiting N/A Interventional Study
Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
96 (estimated)
Sponsor
University Hospital, Brest · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Lung cancer is highly prevalent, with approximately 46,363 new cases in 2018, accounting for 20.6% of cancer deaths in France. At diagnosis, 70% of patients have advanced or metastatic cancer, treatable only by palliative care. Respiratory rehabilitation aims to reduce symptoms, enhance performance, increase autonomy, and improve patients\' quality of life. While effective for COPD patient…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Histologically proven stage IV non-small cell lung cancer patient * First-line treatment with chemotherapy combined with immunotherapy in the maintenance phase * Adenocarcinoma patient: maintenance with Alimta combined with pembrolizumab * Squamous cell carcinoma patient: main…
Contacts

Florence Jacquemine Péguet-Ménard

06.23.25.64.50

jacquemine.menard@chu-brest.fr

CONTACT